etoposide has been researched along with Jaundice in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hallén, K; Molin, D; Nilsson, T; Nordgren, H; Sangfelt, P; Wanders, A | 1 |
Bansal, P; Dayao, Z; Hu, S; Lynch, D; Rojas Hernandez, CM | 1 |
Aoyagi, S; Fujishita, M; Hisaka, T; Horiuchi, H; Ishikawa, H; Kawashima, Y; Kinoshita, H; Nokita, H; Shirouzu, K; Uchida, S | 1 |
1 review(s) available for etoposide and Jaundice
Article | Year |
---|---|
Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Cisplatin; Cytarabine; Enterococcus faecalis; Etoposide; Fatal Outcome; Fever; Gram-Positive Bacterial Infections; Hodgkin Disease; Humans; Jaundice; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Pancytopenia; Rituximab | 2016 |
2 other study(ies) available for etoposide and Jaundice
Article | Year |
---|---|
Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma - pathological development and restitution.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Intrahepatic; Bleomycin; Carrier Proteins; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Jaundice; Male; Neoplasm Staging; Prednisone; Procarbazine; Rituximab; Syndrome; Vincristine | 2014 |
[The hepatic artery injection chemotherapy and prostaglandin E1 administration for hepatocellular carcinoma invading the biliary tract with jaundice].
Topics: Aged; Alprostadil; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cyclophosphamide; Doxorubicin; Etoposide; Fluorouracil; Humans; Injections, Intra-Arterial; Jaundice; Liver Neoplasms; Male | 2005 |